← Every company
Aptevo Therapeutics Inc SEC Filings
What Aptevo Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
APVO overview →Filings on file
172
since Nov 14, 2016
Warning signs
8
latest Jun 23, 2025
Last results
Aug 14, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Feb 3, 2026 | Executive or director change 8-K | Read ↗ |
| Mar 7, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 21, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 27, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 13, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2019 | Executive or director change 8-K | Read ↗ |
| Oct 28, 2019 | Executive or director change 8-K | Read ↗ |
| Oct 3, 2019 | Executive or director changeResults announced 8-K | Read ↗ |
| Jun 1, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 1, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 24, 2017 | Executive or director change 8-K | Read ↗ |
Source: Aptevo Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.